ClinicalTrials.gov
public full text
Public Domain
Effectiveness of Naltrexone and Lofexidine in Treating Detoxified Heroin Addicts - 1
Stress is one of the more common reasons cited by addicts for continual drug use and relapse. Treatment approaches that target both drug-induced and stress-induced relapse may prove to be more beneficial than targeting drug-induced relapse alone. Lofexidine is a drug that reduces the physical symptoms of opiate withdrawal and may prove to have stress-reducing capabilites in drug addicts. The purpose of this study is to determine the maximal safe dose of lofexidine tolerated in naltrexone-treated heroin addicts and to find an optimal lofexidine induction schedule.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment I(2) - 2#886460
- Lofexidine for Inpatient Opiate Detox#1161910
- Comparison of Buprenorphine and Methadone - 3#969315
- Comparison of Three Opioid Detoxification Treatment Regimens#806482
- Buprenorphine vs. Opioid Dose Escalation Among Patients With Chronic Pain#1170960
Record · ID 1163854
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive